Trial Profile
Clinical research of capecitabine in the adjuvant chemotherapy of postoperative liver cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 May 2012
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 29 Sep 2009 Actual initiation date (Jan 2005) added as reported by Chinese Clinical Trial Register.
- 11 Aug 2009 New trial record